01764nam 2200421Ia 450 991069836500332120071004114958.0(CKB)4970000000031305(OCoLC)173661664(EXLCZ)99497000000003130520071004d2007 ua 0engurmn|||||||||txtrdacontentcrdamediacrrdacarrierFood and Drug Administration[electronic resource] methodologies for identifying and allocating costs of reviewing medical device applications are consistent with federal cost accounting standards, and staffing levels for reviews have generally increased in recent yearsWashington, DC :U.S. Govt. Accountability Office,[2007]13 pages digital, PDF fileTitle from title screen (viewed on Sept. 17, 2007).Author: Robert E. Martin."June 25, 2007."Paper version available from: U.S. Govt. Accountability Office, 441 G St., NW, Rm. LM, Washington, D.C. 20548."GAO-07-882R."Includes bibliographical references.Food and Drug AdministrationUser chargesGovernment policyUnited StatesMedical instruments and apparatus industryGovernment policyUnited StatesUser chargesGovernment policyMedical instruments and apparatus industryGovernment policyMartin Robert E191274United States.Government Accountability Office.GPOGPODOCUMENT9910698365003321Food and Drug Administration3471805UNINA